Recent Articles from Chartmill
ChartMill is a comprehensive online stock research platform designed to empower traders and investors with advanced tools for technical and fundamental analysis. The company provides a robust stock screener that allows users to filter thousands of stocks across major exchanges like NYSE, NASDAQ, and EURONEXT, using over 180 customizable technical and fundamental parameters to identify trading opportunities.
Website: https://www.chartmill.com
Wingstop's Q3 2025 earnings beat EPS estimates but missed revenue targets, causing a stock dip despite record unit growth and profitability.
Via Chartmill · November 4, 2025
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system.
Via Chartmill · November 4, 2025
Rhythm Pharmaceuticals posts mixed Q3 2025 results, missing revenue estimates. Despite the loss, the company highlights strong drug growth and key regulatory milestones for its obesity treatments.
Via Chartmill · November 4, 2025
Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug.
Via Chartmill · November 4, 2025
First Watch's Q3 2025 earnings show a revenue beat but an EPS miss. The stock faced pressure despite strong same-store sales growth of 7.1% and aggressive restaurant expansion.
Via Chartmill · November 4, 2025
Nuveen Churchill Direct Lending (NCDL) reported mixed Q3 2025 results, beating EPS estimates but missing on revenue. NAV dipped slightly amid market shifts.
Via Chartmill · November 4, 2025
Learn how a proven growth investing strategy identified Palantir (PLTR) as a top stock, highlighting its explosive earnings, sales growth, and strong cash flow.
Via Chartmill · November 4, 2025
Global Payments (GPN) reported Q3 2025 results with a slight revenue miss but solid adjusted EPS growth and a 6.4% stock rise. The company advances its transformation and Worldpay acquisition.
Via Chartmill · November 4, 2025
STRIDE INC (LRN) excels with strong revenue growth, high profitability, and exceptional capital returns, making it a top pick in the Caviar Cruise quality investing screen.
Via Chartmill · November 4, 2025
Janus Henderson Group (JHG) is a value stock trading below market multiples. It offers strong financial health, a solid 3.67% dividend yield, and steady earnings.
Via Chartmill · November 4, 2025
Discover how Phibro Animal Health (PAHC) combines strong technical trends with accelerating earnings and revenue growth, signaling a potential high-momentum investment.
Via Chartmill · November 4, 2025
Procore stock shows a strong technical breakout setup with firm momentum and a high-quality consolidation pattern, suggesting a potential upward move.
Via Chartmill · November 4, 2025
Enpro (NPO) beat Q3 2025 revenue and EPS estimates, driven by strong performance in semiconductor and aerospace markets. The company also raised its full-year guidance.
Via Chartmill · November 4, 2025
Waters Corp (WAT) beat Q3 2025 earnings and revenue estimates, reporting strong 8% sales growth and non-GAAP EPS of $3.40.
Via Chartmill · November 4, 2025
Eaton (ETN) reported record Q3 2025 EPS of $3.07, beating estimates. Despite a revenue miss, strong Electrical and Aerospace segments drove record margins and optimistic guidance.
Via Chartmill · November 4, 2025
Life Time Group Q3 2025 results beat analyst expectations, with a 21% EPS beat and strong revenue growth. The stock rose in pre-market trading.
Via Chartmill · November 4, 2025
Apollo Global Management Q3 2025 earnings beat EPS estimates but missed on revenue. Stock rose in pre-market trading on strong profitability.
Via Chartmill · November 4, 2025
Graphic Packaging (GPK) topped Q3 2025 EPS and revenue estimates, but its stock fell on weaker-than-expected full-year revenue guidance.
Via Chartmill · November 4, 2025
EVE Holding's Q3 2025 results show a smaller-than-expected loss as the eVTOL developer progresses toward certification and commercialization.
Via Chartmill · November 4, 2025
MPLX LP Q3 2025 earnings crush estimates with $1.52 EPS and a 12.5% distribution increase, boosting investor confidence.
Via Chartmill · November 4, 2025
Henry Schein Q3 2025 earnings beat profit estimates, driving a 7% stock surge. The company also raised its full-year EPS guidance, signaling strong operational momentum.
Via Chartmill · November 4, 2025
Exelon Corp (EXC) Q3 2025 earnings beat analyst forecasts for EPS and revenue, prompting a positive market reaction and reaffirmed full-year guidance.
Via Chartmill · November 4, 2025
Norwegian Cruise Line (NCLH) reported mixed Q3 2025 results with an EPS beat but a revenue miss, causing a sharp stock drop despite raising its full-year outlook.
Via Chartmill · November 4, 2025
Ecovyst Q3 2025 results: EPS beats estimates but revenue misses. The stock declined in pre-market trading following the mixed earnings report.
Via Chartmill · November 4, 2025
Spotify's Q3 2025 earnings crush expectations, with EPS and revenue beats sparking a 3.4% pre-market stock rally.
Via Chartmill · November 4, 2025
Marathon Petroleum's Q3 2025 results show a strong revenue beat but a miss on earnings per share, leading to a sharp negative market reaction.
Via Chartmill · November 4, 2025
ADM's Q3 2025 results were mixed, with earnings beating estimates but revenue missing. The company cut its full-year profit guidance, citing lower crush margins.
Via Chartmill · November 4, 2025
SNDL stock plunges 16% after Q3 2025 earnings report reveals a significant EPS miss, overshadowing a slight revenue beat and strong cash flow.
Via Chartmill · November 4, 2025
Dr. Reddy's Laboratories aligns with Peter Lynch's GARP strategy, showing strong financial health, steady earnings growth, and an attractive valuation with a low PEG ratio.
Via Chartmill · November 4, 2025
Yum China Q3 2025: EPS beats estimates, revenue slightly misses. Strong operational growth and profit increase drive positive investor reaction.
Via Chartmill · November 4, 2025
Molson Coors (TAP) reported a Q3 2025 revenue and earnings miss, leading to a $2.93B net loss due to major impairment charges. The stock fell on the news.
Via Chartmill · November 4, 2025
Stanley Black & Decker's Q3 2025 results show a mixed quarter, beating EPS estimates but missing on revenue, causing the stock to drop.
Via Chartmill · November 4, 2025
InfuSystem Q3 2025: EPS beats estimates, revenue slightly misses. Strong earnings, expanding margins, and robust cash flow highlight profitable growth strategy.
Via Chartmill · November 4, 2025
Kura Oncology reported a Q3 2025 revenue miss but a narrower loss. Investors focus on the upcoming FDA decision for its lead drug, ziftomenib, a key catalyst.
Via Chartmill · November 4, 2025
TopBuild (BLD) beat Q3 2025 earnings estimates and raised its full-year guidance, reflecting strong performance and gains from recent acquisitions.
Via Chartmill · November 4, 2025
Brightstar Lottery Q3 2025 results: EPS of $0.36 beats estimates by 50%, while revenue of $629M misses forecasts. Stock gains in pre-market trading.
Via Chartmill · November 4, 2025
Ingredion (INGR) Q3 2025 earnings and revenue miss analyst estimates. The company also lowered its full-year 2025 guidance, citing operational challenges and shifting demand.
Via Chartmill · November 4, 2025
Patria Investments (PAX) Q3 2025 earnings beat estimates, with EPS of $0.30 and revenue of $84.6M. The stock rose in pre-market trading on the strong results.
Via Chartmill · November 4, 2025
Douglas Elliman Q3 2025 results: Revenue missed estimates, but shares rose on improved EBITDA, a debt-free balance sheet, and strategic growth initiatives.
Via Chartmill · November 4, 2025
SOPHiA GENETICS Q3 2025 results beat revenue estimates and the company raised its full-year 2025 outlook, driving positive investor sentiment.
Via Chartmill · November 4, 2025
Pfizer Q3 2025 earnings beat estimates and the company raised its full-year profit guidance, highlighting strong cost management and non-COVID portfolio growth.
Via Chartmill · November 4, 2025
Leidos (LDOS) Q3 2025 earnings beat estimates on revenue and EPS. The defense tech firm also raised its full-year guidance, signaling strong performance.
Via Chartmill · November 4, 2025
Capri Holdings (CPRI) reported mixed Q2 FY2026 results, with revenue beating estimates but earnings per share missing. The stock rose as the firm focuses on Michael Kors and Jimmy Choo after the Versace sale.
Via Chartmill · November 4, 2025
Gartner Q3 2025: EPS beats estimates but revenue falls short. Strong profitability and record buybacks contrast with slower top-line growth.
Via Chartmill · November 4, 2025
CF Industries (CF) appears undervalued with strong fundamentals, low P/E ratios, robust profitability, and a solid financial position, making it a potential pick for value investors.
Via Chartmill · November 4, 2025
Vishay Precision Group (VPG) exceeded Q3 2025 earnings and revenue forecasts, driving a positive market reaction. The company reported strong sensor segment growth and provided solid forward guidance.
Via Chartmill · November 4, 2025
Ball Corp's Q3 2025 results show revenue in line with forecasts but a miss on earnings per share, triggering a negative pre-market stock reaction.
Via Chartmill · November 4, 2025
Discover how Sprott Physical Gold Trust (PHYS) aligns with Peter Lynch's GARP strategy, featuring strong EPS growth, zero debt, and a low PEG ratio for value-focused gold exposure.
Via Chartmill · November 4, 2025
Alphabet (GOOGL) excels as a top-tier quality stock, showcasing strong revenue growth, high profitability, and a robust balance sheet with minimal debt.
Via Chartmill · November 4, 2025
Franklin Electric (FELE) exemplifies the Caviar Cruise quality investing strategy with high ROIC, strong cash flow, and low debt. A solid long-term pick despite premium valuation.
Via Chartmill · November 4, 2025
ACADIA Pharmaceuticals (ACAD) shows strong growth fundamentals and a positive technical setup, making it a stock to watch for a potential breakout.
Via Chartmill · November 4, 2025
The Caviar Cruise method identifies quality investments like NYT, highlighting its strong financials, zero debt, and excellent profit quality for long-term growth.
Via Chartmill · November 4, 2025
TransMedics Group (TMDX) is a GARP stock with strong revenue & EPS growth, reasonable valuation vs. peers, and a solid financial position.
Via Chartmill · November 4, 2025
Photronics (PLAB) is a potential value stock with strong valuation metrics, a healthy debt-free balance sheet, and solid profitability in the semiconductor industry.
Via Chartmill · November 4, 2025
Innodata (INOD) aligns with the Minervini strategy, showing a strong technical uptrend and explosive earnings growth of 40,900% in its latest quarter.
Via Chartmill · November 4, 2025
Paylocity excels as a Caviar Cruise investment with strong growth, high profitability, and a robust financial position, ideal for long-term investors.
Via Chartmill · November 4, 2025
Despite a strong showing from a few tech giants, Monday’s market breadth deteriorated sharply, with most stocks declining and key breadth metrics reversing course. The data confirms a continuation of weakening participation beneath the surface, raising red flags about the sustainability of the broader market’s gains.
Via Chartmill · November 4, 2025
BWX Technologies (BWXT) stock shows strong technical and fundamental growth momentum, meeting strict trend-following and earnings acceleration criteria.
Via Chartmill · November 4, 2025
Comfort Systems USA (FIX) stock excels with a perfect technical rating and accelerating earnings growth, meeting high momentum and trend criteria for potential market leadership.
Via Chartmill · November 4, 2025
EMCOR Group (EME) offers strong growth at a reasonable price (GARP) with robust earnings, high profitability, and a debt-free balance sheet.
Via Chartmill · November 4, 2025
Winnebago (WGO) appears undervalued with strong financial health, a solid 3.75% dividend yield, and promising growth prospects. A compelling value stock for further research.
Via Chartmill · November 4, 2025
Schlumberger (SLB) aligns with Peter Lynch's GARP strategy, showing strong earnings growth, a low PEG ratio, and solid financial health for long-term investors.
Via Chartmill · November 4, 2025
CTRA stock offers strong growth at a reasonable price. With solid profitability and a cheap valuation, it's a top GARP investment pick.
Via Chartmill · November 4, 2025
Micron Technology stock combines strong technicals via the Minervini Trend Template with explosive fundamental growth in earnings and sales.
Via Chartmill · November 4, 2025
A $38 billion partnership between Amazon and OpenAI reignited AI enthusiasm on Wall Street, sending tech stocks higher while the broader market faltered. Palantir impressed with record earnings, but most S&P 500 stocks closed in the red.
Via Chartmill · November 4, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · November 3, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.
Via Chartmill · November 3, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · November 3, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · November 3, 2025
Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via Chartmill · November 3, 2025
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below.
Via Chartmill · November 3, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · November 3, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · November 3, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · November 3, 2025
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends.
Via Chartmill · November 3, 2025